![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 42, 39209-39216, October 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, June 27, 2002, and in revised form, July 30, 2002
E-cadherin protein plays a key role in the
establishment and maintenance of adherent junctions. Recent
evidence implicates the transcription factor Snail in the blockage of
E-cadherin expression in fibroblasts and some epithelial tumor cells
through direct binding to three E-boxes in the E-cadherin promoter.
Transfection of Snail into epithelial cells leads to a more
fibroblastic phenotype. Cells expressing Snail presented a scattered
flattened phenotype with low intercellular contacts. Other
epithelial markers like Cytokeratin 18 or MUC1 were also repressed. The
effects of Snail on MUC1 transcription were mediated by two E-boxes
present in the proximal promoter. Snail also induced expression of
the mesenchymal markers fibronectin and LEF1 and the transcription
repressor ZEB1. ZEB1 and Snail had a similar pattern of expression in
epithelial cell lines, and both were induced by overexpression of ILK1,
a kinase that causes the loss of E-cadherin and the acquisition of a
fibroblastic phenotype. Snail overexpression in several cell lines
raised ZEB1 RNA levels and increased the activity of ZEB1 promoter.
ZEB1 could also repress E-cadherin and MUC1 promoters but less
strongly than Snail. However, since ZEB1 expression persisted after
Snail was down-regulated, ZEB1 may regulate epithelial genes in several
tumor cell lines.
The poor prognosis in epithelial neoplasia is associated
with the acquisition of motile or invasive properties by the cancerous cells. This morphological transformation is often referred to as
epithelial mesenchymal transition
(EMT).1 EMT was first
described in development when it is closely regulated and associated
with processes like gastrulation or neuroepithelium formation.
Molecular events during EMT include alterations in cell-cell adhesion,
cell-substrate interaction, extracellular matrix degradation,
and cytoskeleton organization. During EMT, epithelial markers are
down-regulated, among them E-cadherin, a protein essential for the
establishment of cell-cell adhesion (for review, see Refs. 1-3).
In cancerous cells there is a high correlation between invasion and
metastasis and the loss of E-cadherin (4, 5), whereas during
gastrulation E-cadherin is down-regulated in progenitor cells in the
primitive streak (6). Control of E-cadherin transcription is the main
mechanism responsible for the down-regulation of this protein (7, 8). A
transcriptional factor called Snail (SNA in humans and Sna in mice)
represses E-cadherin transcription in vitro and in
vivo by binding to a 5'-CACCTG-3' sequence of the E-cadherin
promoter (9). Transfection of Snail in epithelial cells decreases
E-cadherin levels and induces changes resembling EMT (9, 10). In
addition, Snail is believed to contribute to the EMT in several
experimental models. For instance, during Drosophila
gastrulation, Snail function is required for the repression in the
mesoderm of genes that are otherwise expressed in the adjacent neuroectodermal regions of the blastoderm (11). Further evidence was
obtained from Sna In this study we have examined with greater detail the changes induced
by the ectopic expression of Sna in epithelial cells. In
addition to showing the ultrastructural modifications observed in cells
expressing Sna, we have also characterized several genes that show an altered expression. One of these genes is
ZEB1,2 a
transcriptional repressor also capable of blocking the expression of
E-cadherin. The data obtained together with data previously reported
clearly show that Snail induces a complete EMT.
Cell Culture--
The generation of Madin-Darby canine kidney
(MDCK) cells and HT-29 M6 cells transfected with Sna-HA has
been described (9). HT-29 M6 SNA1 and SNA2 correspond to two clones
obtained by transfection with a tet-regulated expression vector
(tet-off) containing hemagglutinin-tagged mouse Snail
cDNA (Sna). MDCK SNA1 and SNA3 are two MDCK
Sna-expressing clones obtained by transfection of MDCK cells with
pIRES-neo Sna-HA (9). IEC-18 rat cells transfected with
wild-type or negative forms of ILK or with an antisense construction of
this kinase were obtained as described previously (14). Other human
(HT-29, SW-480, SW-620, ZR-75, T47D, MCF-7, MiaPaca, and RWP-1) or
mouse (EpH4 and NIH-3T3) cell lines were obtained from our institute Cell Bank. All cells were grown in Dulbecco's modified Eagle's medium
(Invitrogen) containing 10% fetal calf serum (Biological Industries)
and the standard supplements.
DNA Constructions and Other Reagents--
Murine ZEB1
cDNA was provided by T. Genetta (Children's Hospital of
Philadelphia, Philadelphia, PA) and cloned into pcDNA3HisC expression vector (Promega) at the EcoRI site.
ZEB2-CS2MT expression vector was kindly provided by A. Postigo (Washington University, St. Louis, MO). Sna-HA was
cloned into RSV 5 expression vector inserting the 0.9-kb
HindIII-NotI fragment from pcDNA3
Sna-HA at the XhoI site of RSV 5. Blunt ends were
generated using the Klenow fragment from DNA polymerase (New England
Biolabs). Commercial anti-ZEB1 was obtained from Santa Cruz
Biotechnology (goat anti-ZEB1 C-20, sc-10570) and monoclonal
anti-E-cadherin from Transduction Laboratories (c20820). Antiserum
against recombinant mouse Snail was raised in New Zealand rabbits by
standard protocols and purified by affinity chromatography using
recombinant murine Snail.
Semithin Sections and Electron Microscopy--
Postconfluent
cells were fixed in 2% glutaraldehyde for 30 min and embedded in EPON
(Tousimis Research Corp., Rockville, MD). Semithin and ultrathin
sections were obtained and stained using standard procedures. For
electron microscopy, ultrathin sections were observed using a Philips
CM100 electron microscope.
Analysis of Transcripts--
Northern blots were performed
following a standard protocol. Briefly, 12.5 µg of total RNA isolated
by guanidinium isothiocyanate extraction were separated in a denaturing
agarose/formaldehyde gel, visualized with ethidium bromide staining,
photographed, and transferred to a Zeta-probe (Bio-Rad) membrane
overnight by capillarity action. The next day RNA was cross-linked to
the membrane using a GS Gene linker (Bio-Rad) and hybridized with
radiolabeled [
RT-PCR analysis from 0.5-1 µg of isolated total RNA was performed
using SuperScript One-Step RT-PCR with Platinum Taq
polymerase (Invitrogen). The following pairs of primers
(sense/antisense) were used: hsZEB1,
5'-TTCAGCATCACCAGGCAGTC-3' (947-966)/5'-GAGTGGAGGAGGCTGAGTAG-3' (1663-1683); hsZEB2, 5'-GCTACGACCATACCCAGGAC-3'
(2756-2776)/5'-TCTCGCCCGAGTGAAGCC-3' (3139-3157); Sna,
5'-GGCGGATCCACCATGCCGCGCTCCTTCCTGGTC-3'
(1-24)/5'-CCGGATATCCGCGAGGGCCTCCGGAGCA-3' (778-791); SNA,
5'-TTCCAGCAGCCCTACGACCAG-3' (104-125)/5'-GCCTTTCCCACTGTCCTCATC-3' (290-310); hs Cyclophilin A: 5'-ATGGTCAACCCCACCGTG-3'
(45-62)/5'-TGCAATCCAGCTAGGCATG-3' (690-708); hs Fibronectin,
5'-GTGCCTGGGCAACGGA-3' (922-938)/5'-CCCGACCCTGACCGAAG-3' (1554-1571);
hs Cytokeratin 18, 5'-CTGGAGACCGAGAACCGGA-3'
(352-370)/5'-tccgagccagctcgtcaT-3' (818-835); hsMUC1,
5'-catgGTACCGCAAGGCTCCCGGTGACC-3'
(556-574)/5'-CGTAAGCTTGGGAGGGGGCAGAACAGATT-3' (748-765); hs
E-cadherin, 5'-TTCCTCCCAATACATCTCCCTTCACAGCAG-3' (1977-2006)/5'-CGAAGAAACAGCAAGAGCAGCAGAATCAGA-3' (2287-2316); and
hsLEF1, 5'-CTGCGCCACGGACGAG-3'
(704-720)/5'-GAGAGGATGGACCGCATGG-3' (1098-1116). The sense and
antisense primers anneal with different exons. The number of cycles and
annealing temperatures were: ZEB1, 40 at 53 °C;
ZEB2, 28 at 55 °C; SNA, 32 at 60 °C;
Sna, 39 at 60 °C; hsMUC1, 30 at 60 °C; hs
E-cadherin, 29 at 55 °C; hs Fibronectin, 30 at 55 °C;
hsLEF1, 35 at 55 °C; hs Cytokeratin 18, 40 at 55 °C;
and hs Cyclophilin A, 22 at 60 °C. The sequences indicated correspond to those stored in the GenBankTM under the
following accession numbers: hsZEB1, U12170;
hsZEB2, AB011141; SNA, NM005985; Sna,
M95604; hsMUC1, X80671; hs E-cadherin, AB025106; hs
Fibronectin, X02761; hsLEF1, AF288571; hs Cytokeratin 18, M26326; and hs Cyclophilin A, BC005320.
Cloning of MUC1 and ZEB1 Promoters--
The human
MUC1 promoter sequence containing
Human ZEB1 promoter ( Analysis of Promoter Activity--
Repression of E-cadherin or
MUC1 promoter activity was measured by cotransfecting
ZEB or Sna constructions in pcDNA3 plasmid (Invitrogen) with pGL3-E-cadherin or -MUC1 promoters in the
indicated cell lines. Cotransfections included a Renilla
reniformis luciferase plasmid (pRTK-Luc or
pRSV-Luc from Promega) to normalize transfection efficiency.
Firefly luciferase (Luc) and Renilla luciferase activities were measured using the Dual Luciferase Reporter Assay System (Promega)
48 h after transfection according to the manufacturer's instructions. Luc activity was normalized by Renilla
luciferase activity. In all experiments, the total amount of DNA
transfected was standardized with empty vector. Duplicates or
triplicates were systematically included, and experiments were repeated
at least three times. ZEB1 or MUC1 promoter
activity in Sna clones was assayed by cotransfecting varying amounts of
pGL3-ZEB1 or -MUC1 promoter reporter and
pRTK-Luc and measuring luciferase activity as mentioned above.
Analysis of Protein Expression--
Cells were seeded on
1-cm-diameter cover glasses, left to grow to 40-70% confluence, fixed
with 4% paraformaldehyde, blocked with 5% milk in phosphate-buffered
saline, and incubated with specific antibodies. Fluorescein
isothiocyanate-conjugated anti-goat or anti-rabbit (DAKO) was used as
second antibody. Immunofluorescent labeled cells were observed in a
fluorescent microscope (Axioskop). Alternatively, protein expression
was determined by Western blot using 15 µg of lysates obtained by
boiling the cells in 1% SDS.
The fibroblastoid morphology of several of the Sna-transfected
HT-29 M6 and MDCK cell clones used in this work is shown in Fig.
1. The main attribute of these cells is
the failure to form compacted colonies and a more scattered aspect. In
HT-29 M6 clones transfected with the tet-off system, the
epithelial phenotype was restored by addition of the tetracycline
analogue doxycycline, which prevents expression of Snail (Fig. 1 and
Ref. 9).
Lateral sections obtained from HT-29 M6 clones illustrate that
Snail overexpression prevented the formation of the compact columnar
epithelial-like monolayer characteristic of HT-29 M6 cells and reduced
the thickness from 12-16 to 4-6 µm (Fig.
2, left panels). HT-29 M6 SNA1
clone, like the other Sna-expressing clones, showed a flattened,
fibroblast-like phenotype with cells disposed occasionally on the top
of others. No cell contacts were observed in these transfectants in
contrast to control HT-29 M6 clones where tight junctions, adherens
junctions, and desmosomes were seen (Fig. 2, right panels).
These control clones also showed closer apposition of lateral membranes
and other characteristics of well differentiated epithelial cells like
microvilli and mucus droplets.
Snail Induction of Epithelial to Mesenchymal Transition in Tumor
Cells Is Accompanied by MUC1 Repression and
ZEB1 Expression*
§¶,
§
,
,
,
,
**,
**,
,
§§, and
¶¶
Unitat de Biologia Cellular i Molecular,
Institut Municipal d'Investigació Mèdica, Universitat
Pompeu Fabra, E-08003 Barcelona, Spain and the

Department of Biochemistry and Molecular
Biology, University of British Columbia, Vancouver, British Columbia
V6H 3Z6, Canada
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/
mouse embryos, which show an
incomplete EMT: a new mesoderm is formed, but the resulting cells
maintain epithelial markers like E-cadherin (12). Other mutants that show defects in EMT and cell migration during gastrulation are fibroblast growth factor receptor 1 (
/
) animals; these
defects have been attributed to a severe reduction of Snail expression in the primitive streak accompanied by ectopic expression of E-cadherin (13). Several conditions also induce EMT in epithelial cell lines (3).
Snail is involved in a number of processes: for instance,
activation of integrin-linked kinase (ILK), which mediates extracellular matrix signals (14, 15), increases Snail promoter activity and down-regulates E-cadherin (16). Finally, increased Snail
expression has been described in some carcinogenic cell lines with
invasive capacity (10, 17-19).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]dCTP probes (rediprime
II, Amersham Biosciences) using ExpressHyb solution
(CLONTECH). MUC1 DNA probe was prepared from 50 ng
of purified MUC1 cDNA cytosolic sequence, amplified by
reverse transcription coupled to polymerase chain reaction (RT-PCR)
from HT-29 M6 total RNA using the oligonucleotides
5'-CGAAAGCTTGCCGCCGAAAGAACTACG-3' (sense, 556-574) and
5'-GAGGATATCGCAAGTTGGCAGAAGTGGC-3' (antisense, 748-765)
corresponding to a sequence stored in the GenBankTM
(accession number X80671). Specific bands were visualized by
autoradiography using Hyperfilm MP (Amersham Biosciences).
756 to +49 bp from the
transcription start site was cloned by PCR from HT-29 genomic DNA using
high fidelity Taq polymerase (Pfx, Invitrogen) and
oligonucleotides 5'-catgGTACCGCAAGGCTCCCGGTGACC-3' (2114-2133) and
5'-CGTAAGCTTGGGAGGGGGCAGAACAGATT-3' (2900-2919) corresponding to
GenBankTM sequence X69118 containing KpnI and
HindIII restriction sites at the ends. Purified PCR product
was cloned into the KpnI and HindIII sites of a
mutated version (9) of pGL3 Luciferase vector (Promega) (a putative
Snail binding site of the plasmid was eliminated). A MUC1
promoter mutant in the two E-boxes, E-MUC (MUT), was obtained using the
QuikChangeTM site-directed mutagenesis kit (Stratagene, La
Jolla, CA). The sense oligonucleotide sequence was
5'-GAGGGGGCGGGGTTTTGTAAACCTATAACCTACTCGCTGTGCCTAGGGCCG-3', where mutated nucleotides are indicated in bold.
361 to
53 from the translation
start) was amplified from the same source using oligonucleotides
5'-CCGCCGAGCCTCCAACTTTA-3' (3119980-3119998) and
5'-CCTTCCCCCCCACCCCTCC-3' (3120269-3120287) corresponding to
NCBI contig number NT_033982, containing MluI and
HindIII sites at the 5'-ends, respectively. The fragment was cloned into the mutated version of pGL3 at the MluI and
HindIII sites. All constructs were confirmed by sequencing.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (74K):
[in a new window]
Fig. 1.
Morphology of HT-29 M6 and MDCK clones
transfected with Sna. Photographs were taken at
×200 (MDCK) or ×320 (HT-29 M6) magnification of cell lines expressing
Sna. When indicated (+tet), HT-29 M6 Sna clones
were grown in the presence of doxycycline (2 µg/ml). CONT,
control.

View larger version (78K):
[in a new window]
Fig. 2.
Semithin sections and electron microscopy of
Sna-transfected HT-29 M6 cells. HT-29 M6 control and SNA1 clones
were grown up to confluence. Semithin sections (left panels)
and ultrathin sections visualized with an electron microscope
(right panels) are shown. M, mucus droplets;
MV, microvilli; TJ, tight junction;
AJ, adherent junction; D, desmosome;
N, nucleus; CON, control.
Some cell properties were also altered in the Sna transfectants, compatible with the transition from an epithelial to a mesenchymal phenotype. In addition to a decrease in intercellular adhesion (Figs. 1 and 2, and data not shown), Sna-expressing clones attached better to plastic and spread faster on several matrices such as collagen or laminin (data not shown). Increases in these two parameters are observed in fibroblasts with respect to well differentiated epithelial cells like HT-29 M6. HT-29 M6 Sna clones treated with doxycycline were indistinguishable from controls (not shown).
We also determined whether these changes in phenotype were accompanied
by alterations in the expression of different genes. Using a
semiquantitative RT-PCR analysis, we found RNA levels of several
epithelial genes, other than E-cadherin, to be decreased in
Sna-transfected clones of HT-29 M6 cells (Fig.
3). Expression of MUC1 and
Cytokeratin 18, which contain putative Snail-binding sequences in their
promoters (see below), decreased in Sna-transfected clones. On the
other hand, Fibronectin, LEF1, and ZEB1 were
up-regulated in Sna transfectants. Increased levels of Fibronectin have
already been reported in MDCK cells transfected with Snail (10); the augmentation in the synthesis of this protein might be responsible for
the higher rate of attachment and spreading of Sna clones. ZEB1 and
LEF1 are two transcription factors related to mesenchymal phenotypes.
LEF1 is the preferential LEF/T cell factor isoform in
mesenchymal cells and is differentially expressed in some neoplastic processes such as colon cancers (20). On the other hand, ZEB1 is
a transcriptional factor recently described to be involved in
E-cadherin repression (21). To investigate the changes in gene
expression that accompany this epithelial to mesenchymal transition we
decided to analyze in greater detail the modulation of two
representative genes: one, MUC1, that is repressed, and another one, ZEB1, that is activated.
|
MUC1 is a marker of several epithelial tissues including the colonic
epithelium. Its promoter sequence contains a tandem repeat of the
consensus Snail DNA binding sequence situated at
84 bp from the
transcription start (22). Therefore, like E-cadherin, this gene is a
putative direct target of Snail. Northern blots corroborated that
MUC1 RNA levels were significantly lower in Sna-expressing
HT-29 M6 clones than in controls (Fig.
4A). Then we analyzed whether
the Snail-induced decrease of MUC1 RNA was a consequence of
a repression of the activity of the promoter. An 800-bp MUC1
gene fragment, corresponding to sequence containing
756 to +49 with
respect to the transcription start (22), was cloned and inserted
into the pGL3 plasmid upstream of the luciferase reporter gene. This
promoter has been described to be active in epithelial cell lines
expressing MUC1 (22). MUC1 transcriptional activity was
lower in the Sna transfectant clones than in control or parental cells
(Fig. 4B). The Snail-induced repression of the MUC1 promoter was reproduced when Snail was transiently
transfected in HT-29 M6 parental cells or other MUC1-expressing
epithelial cells. In all cases, Snail repressed the activity of the
promoter in a dose-dependent manner by up to 80% (Fig.
4C). This repression was not observed with the Sna mutant
Pro-2
Ala (data not shown), which does not block E-cadherin
promoter activity (9). Modification of the putative Snail-binding
element in the promoter (mutation of
5'-cacctgtcacctg-3' to
5'-aacctataaccta-3')
prevented the decrease in MUC1 promoter activity (Fig.
4C). A similar mutation has been reported to inhibit binding
of Snail to E-cadherin promoter E-boxes and repression of this promoter
(9). Therefore, the presence of a Snail binding sequence is required to
block MUC1 transcription. These results demonstrate that
Snail represses directly the expression of at least another epithelial
marker in addition to E-cadherin.
|
The induction of ZEB1 expression was also investigated. As
mentioned above, ZEB1 is also a transcriptional repressor capable, like Snail, of preventing the activity of the E-cadherin promoter. First, the expression of these three genes
(SNA/Sna, ZEB1, and E-cadherin) was
analyzed in a collection of epithelial cell lines expressing variable
amounts of E-cadherin. Because of the low amounts of transcription
factor RNAs present in a total RNA preparation, we used RT-PCR to
detect Sna and ZEB1. Only in those cell lines in
which Snail and ZEB1 were coexpressed was E-cadherin
severely down-regulated (Fig. 5,
upper panels). In a few cell
lines, like EpH4, we detected simultaneous expression of both
E-cadherin and Snail but not ZEB1.
|
We also analyzed whether the expression of Snail is induced in conditions in which cells undergo EMT. We used as a model IEC-18 epithelial cells that undergo EMT when transfected with ILK (14). When an active ILK was expressed, IEC-18 cells acquired a fibroblastoid phenotype that correlated with a down-regulation of E-cadherin. Although Snail was detected in these cells, overexpression of ILK induced an increase in the RNA corresponding to this gene. We found that the active ILK form also induced ZEB1 RNA (Fig. 5, lower panels). Therefore, ZEB1 seems to be induced concomitantly with Snail and the acquisition of the fibroblastoid phenotype in IEC-18 cells.
The involvement of Snail in ZEB1 activation was evidenced by
our data with Sna transfectants. As mentioned above (see Fig. 3), in
our Sna-expressing HT-29 M6 clones ZEB1 RNA levels were increased. A more detailed study was performed in these clones taking
advantage of the regulation of the expression of this gene by the
tetracycline analogue doxycycline. ZEB1 RNA transcription was detected only after Snail RNA expression was turned on by withdrawing doxycycline from the medium (Fig.
6). Expression of Sna was
detected 4 days after withdrawing doxycycline, slightly preceding
ZEB1 expression, which required 8 days. Therefore Sna expression is sufficient to trigger the ZEB1 RNA
up-regulation. On the other hand, when Sna expression was
turned off by adding doxycycline, ZEB1 RNA did not disappear
immediately, as did Sna, but diminished gradually.
The stability of ZEB1 RNA in the absence of Snail suggests
that ZEB1 could possibly prolong the repression of epithelial genes
initiated by Snail.
|
This result seems not to be exclusive of these HT-29 M6 clones since
MDCK Sna-transfected clones also showed increased levels of
ZEB1 RNA (Fig. 7A).
The molecular mechanism by which Snail induces ZEB1 was
studied. To test whether Snail induces the transcription of
ZEB1, we cloned a 308-bp DNA fragment upstream of the
ZEB1 first exon and assayed its promoter activity in MDCK
control and Sna-expressing cells. Sna-expressing MDCK clones contained
2.5-fold higher activity than controls of this promoter (Fig.
7B), indicating that Snail increases ZEB1 RNA at
least in part by the activation of the transcription of this gene. To
validate this result we tested the reporter activity in transient
transfection of Snail. In RWP-1 cells Snail also increased the
transcriptional activity of the ZEB1 reporter; however, this
effect was only observed when the activity was determined in cells
transfected longer than 48 h (Fig. 7C).
|
The ZEB1 homologue, ZEB2, has also been described to behave as an E-cadherin repressor (23). However, it did not respond to Snail activation in any of our experiments, and its expression did not correlate with that of Snail in the epithelial cell lines tested; it was detected in all the cell lines analyzed (Figs. 5 and 7A).
As the first step to confirm the putative role of ZEB1 as a repressor
in the Snail activated pathway, we confirmed that ZEB1 protein was also
up-regulated in Sna-transfected clones. A clear increase of this
protein was detected in the nucleus in HT-29 M6 and MDCK clones (Fig.
8). We also analyzed the repression
activity of ZEB1 on E-cadherin promoter transcription in several
epithelial cell lines using a proximal E-cadherin promoter (
178 to
+23) upstream of a luciferase gene reporter. This promoter sequence contains three 5'-CACCTG-3' boxes where Snail and ZEB1 can bind. ZEB1
repressed the promoter activity in a dose-dependent manner with a maximal inhibition of 60-80% in the cell lines tested, which
included RWP-1 (Fig. 9A),
MCF-7 (Fig. 9B), HT-29 M6, and MDCK (data not shown). The
degree of repression obtained with ZEB1 and Snail were comparable;
however, although both were expressed under the same promoter, ZEB1
required a 10-20-fold higher dose to achieve the maximum repression in
the four cell lines assayed. This effect on the E-cadherin promoter was
accompanied by changes in the expression of this protein (not shown).
Thus, ZEB1 also holds the potential to repress E-cadherin
transcription, although less effectively than Snail. On the other hand,
ZEB2 repressed the promoter poorly with a maximum of 40% in MCF-7
cells (Fig. 9B). No synergistic effects were observed in
experiments of simultaneous repression of Sna and ZEB1 on E-cadherin
promoter; inhibitions of the activity of this promoter by both factors
are additive (Fig. 9A).
|
|
We also tested whether ZEB1 repressed another Snail target gene,
MUC1. Reporter assays using the above-described
MUC1 promoter show that, in a fashion similar to Snail, ZEB1
repressed the promoter activity (Fig. 9C). Similar to the
results obtained with E-cadherin promoter, ZEB1 was at least 10-fold
less potent than Snail as a repressor of the MUC1 promoter.
| |
DISCUSSION |
|---|
|
|
|---|
In certain circumstances epithelial cells can undergo extensive changes in their phenotype and convert to mesenchymal cells. This EMT is observed in several phases of embryonic development and in carcinoma cell invasion and metastasis. Transcription of E-cadherin gene is down-regulated during these processes (4, 5). However, EMT involves a decrease of a set of epithelial tissue-specific molecules or markers other than E-cadherin and an increase of mesenchyme-related molecules (1). We (9) and others (10) have reported that the transcriptional repressor Snail blocks E-cadherin expression by binding to specific E-boxes in its promoter, but the mechanism by which levels of other molecules are regulated in EMT is poorly understood. Genetic approaches in Drosophila have showed that two transcription factors, Snail and Twist, regulate the expression of mesenchymal and epithelial genes, although some mesenchymal genes can also be regulated by other transcriptional genes like Dorsal and Tailless (11). Developmental studies (for review, see Ref. 24) as well as data obtained after transfection to epithelial cells indicate that Sna induces a complete EMT when transfected to cultured epithelial cells. We took advantage of this capacity of Sna to study the mechanisms of repression of epithelial genes or activation of mesenchymal genes.
Epithelial genes other than E-cadherin, like MUC1 and Cytokeratin 18, also possess E-boxes on their promoters. Our results show that RNA levels of these genes are decreased after Snail expression (Figs. 3 and 4) and that repression of MUC1 requires intact E-boxes (Fig. 4). Therefore, MUC1 and E-cadherin seem to be regulated by a common mechanism that involves Snail. However, other factors with affinity for this sequence may also participate in the down-regulation of MUC1 and E-cadherin transcription.
Among the genes up-regulated by Snail we found a transcriptional repressor, ZEB1, also capable of binding the same E-boxes as Snail. ZEB1 and ZEB2 are homologues of Drosophila Zfh-1, which is active downstream of Snail in embryonic development. Snail is required for the expression of Zfh-1 in the mesoderm primordium; in Snail mutants, Zfh-1 expression is severely reduced (25). Our results obtained from Sna-inducible and stable clones clearly show that Snail increases ZEB1 RNA (Figs. 5-7) and protein levels (Fig. 8) during EMT. We have also shown, through reporter experiments, that ZEB1 augmentation is due, at least in part, to an elevation of the transcriptional activity of the ZEB1 promoter (Fig. 9B). Although the ZEB1 promoter contains E-box sequences, we do not think that Snail directly activates ZEB1 promoter since (a) the time required to observe the increase of the reporter is longer than the time required to repress E-cadherin or MUC1 promoters (compare Figs. 7C and 9) and (b) ZEB1 expression was detected after 4 days of expression of Snail in a Sna-inducible clone (Fig. 6B).
ZEB1, like Snail, represses E-cadherin and MUC1 transcription when transfected into epithelial cells. Moreover, tumor cell lines with severe reduction of E-cadherin expressed both Snail and ZEB1 (Fig. 3), and Snail and ZEB1 repression activities were additive (Fig. 9). In addition to the up-regulation of ZEB1 RNA in Snail-induced clones, when Snail expression was switched off, ZEB1 expression required more than 20 days to gradually return to basal levels (Fig. 6). This observation indicates that in circumstances of a transient expression of Snail, ZEB1 prolonged Snail-induced repression of epithelial genes. In agreement with this hypothesis, in Drosophila embryos Zfh-1 persists after Snail is down-regulated (26, 27). However, whereas Sna knock-out mutant mice are not viable due to defective gastrulation (12), ZEB1 is dispensable for this process. ZEB1 knock-out animals develop to term, although they show severe deficiencies in T cell production in the thymus and several skeletal defects (28). Therefore, Snail, but not ZEB1, is necessary for the E-cadherin down-regulation required for a correct gastrulation.
The analysis of tumor cell lines with different epithelial or mesenchymal characteristics as well as IEC-18 intestinal cells expressing ILK showed a high inverse relationship between ZEB1 and E-cadherin expression. This relationship is better than that presented by E-cadherin and Snail since we detected several cell lines expressing these two proteins. However, recent data from our laboratory indicates that the presence of Snail does not always correlate with the activity of this factor since in several cell lines, in those that present concomitant expression of E-cadherin, Snail protein is excluded from the nucleus.3 These data, together with those obtained with knock-out mice, suggest that Snail is the key element controlling E-cadherin transcription and triggering EMT and, therefore, ZEB1 expression in most of epithelial cell lines. However, in some tumors, ZEB1 might become unresponsive to Snail activation as a result of mutations in the promoter or the activation of some of its transcriptional activators and might block E-cadherin expression.
All cell lines tested showed expression of ZEB2
independently of Snail and E-cadherin levels. This expression of
ZEB2 was not modified either during ILK-induced EMT of
IEC-18 cells or after induction of Snail. These observations strongly
suggest a different regulation for the expression of the two
ZEB homologues: ZEB1 is induced by Snail and is
specific to fibroblastic cells, whereas ZEB2 is
constitutively expressed in all the cell lines, independently of their
epithelial or mesenchymal lineage. Moreover, although ZEB2 induces
repression of E-cadherin promoter in some cellular contexts (Ref. 23
and Fig. 9B), this factor presents much lower activity than
ZEB1 or Snail. The difference in the repression of E-cadherin between
ZEB1 and ZEB2 may be due to the distinct organization of the regulatory
domains (29). In any case, our results indicate that the endogenous
amount of ZEB2 cannot repress the activity of basal epithelial
promoters in tumor cells. However, due to its ubiquitous expression,
the question of whether ZEB2 cooperates with Snail to repress
epithelial promoters remains to be answered.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Postigo and Genetta for kindly providing reagents. The technical support of Judit Grueso and M. Carmen Torns is greatly appreciated. We also thank Dr. J. Lloreta for help with electronic microscopy.
| |
FOOTNOTES |
|---|
* This work was supported by Ministerio de Ciencia y Tecnología Grant PM99-0132 (to A. G. H.) and Fondo de Investigaciones Sanitarias Grant 01/3060 (to J. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Both authors made equivalent contributions to this work.
¶ Recipient of a predoctoral fellowship from Ministerio de Ciencia y Tecnología (Formación de Personal Investigador) and supported by a predoctoral fellowship "Xavier Lamas" awarded by Institut Municipal d'Assistència Sanitària for the initial work.
** Current address: Dept. of Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands.
Recipient of a predoctoral fellowship from Ministerio de
Educación (Formacion del Profesorado Universitario).
§§ To whom correspondence may be addressed: Institut Municipal d'Investigació Mèdica, c/Doctor Aiguader, 80, E-08003 Barcelona, Spain. Tel.: 34-93-221-1009; Fax: 34-93-221-3237; E-mail: agarcia@imim.es.
¶¶ To whom correspondence may be addressed: Institut Municipal d'Investigació Mèdica, c/Doctor Aiguader, 80, E-08003 Barcelona, Spain. Tel.: 34-93-221-1009; Fax: 34-93-221-3237; E-mail: jbaulida@imim.es.
Published, JBC Papers in Press, August 2, 2002, DOI 10.1074/jbc.M206400200
2
In this study we use the name ZEB1 to
refer to the gene that has also been called ZEB,
AREB6 (in humans), BZP (in hamster), or
EF1 (in chicken) (GenBankTM accession number
U12170) and ZEB2 for the gene also known as SIP1
(GenBankTM accession number
AB011141).
3 D. Domínguez, B. Montserrat, J. Grueso, M. Porta, A. Virgós, C. Francí, J. Baulida, and A. García de Herreros, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: EMT, epithelial to mesenchymal transition; ILK, integrin-linked kinase; LEF, lymphoid enhancer factor; RT, reverse transcription; SNA, human Snail gene, Sna, mouse Snail gene; MDCK, Madin-Darby canine kidney; HA, hemagglutinin; RSV, Rous sarcoma virus; hs, Homo sapiens; Luc, firefly luciferase; tet, tetracycline.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hay, E. D. (1995) Acta Anat. (Basel) 154, 8-20 |
| 2. | Boyer, B., Vallés, A. M., and Edme, N. (2000) Biochem. Pharmacol. 60, 1091-1099[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Savagner, P. (2001) Bioessays 23, 912-923[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and van Roy, F. (1991) Cell 66, 107-119[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. A. (1998) Nature 392, 190-193[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Oda, H., Tsukita, S., and Takeichi, M. (1998) Dev. Biol. 203, 435-450[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Hennig, G.,
Lowrick, O.,
Birchmeier, W.,
and Behrens, J.
(1996)
J. Biol. Chem.
271,
595-602 |
| 8. | Ji, X., Woodard, A. S., Rimm, D. L., and Fearon, E. R. (1997) Cell Growth Differ. 8, 773-778[Abstract] |
| 9. | Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., and García de Herreros, A. (2000) Nat. Cell Biol. 2, 84-89[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. (2000) Nat. Cell Biol. 2, 76-83[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Casal, J.,
and Leptin, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10327-10332 |
| 12. |
Carver, E. A.,
Jiang, R.,
Lan, Y.,
Oram, K. F.,
and Gridley, T.
(2001)
Mol. Cell. Biol.
21,
8184-8188 |
| 13. | Ciruna, B., and Rossant, J. (2001) Dev. Cell 1, 37-49[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Hannigan, G. E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M. G., Radeva, G., Filmus, J., Bell, J. C., and Dedhar, S. (1996) Nature 379, 91-96[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Dedhar, S. (2000) Curr. Opin. Cell Biol. 12, 250-256[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Tan, C., Costello, P., Sanghera, J., Domínguez, D., Baulida, J., García de Herreros, A., and Dedhar, S. (2001) Oncogene 20, 133-140[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Poser, I.,
Dominguez, D.,
Garcia de Herreros, A.,
Varnai, A.,
Buettner, R.,
and Bosserhoff, A. K.
(2001)
J. Biol. Chem.
276,
24661-24666 |
| 18. | Cheng, C. W., Wu, P. E., Yu, J. C., Huang, C. S., Yue, C. T., Wu, C. W., and Shen, C. Y. (2001) Oncogene 20, 3814-3823[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Jiao, W., Miyazaki, K., and Kitajima, Y. (2002) Br. J. Cancer 7, 98-101 |
| 20. | Hovanes, K., Li, T. W., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence-Marsh, J., Holcombe, R. F., and Waterman, M. L. (2001) Nat. Genet. 28, 53-57[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Grooteclaes, M. L., and Frisch, S. M. (2000) Oncogene 19, 3823-3828[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Kovarik, A.,
Peat, N.,
Wilson, D.,
Gendler, S. J.,
and Taylor-Papadimitriou, J.
(1993)
J. Biol. Chem.
268,
9917-9926 |
| 23. | Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. (2001) Mol. Cell 7, 1267-1278[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Nieto, M. A. (2002) Nat. Rev. Mol. Cell Biol. 3, 155-166[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Lai, Z. C., Fortini, M. E., and Rubin, G. M. (1991) Mech. Dev. 34, 123-134[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Leptin, M.
(1991)
Genes Dev.
5,
1568-1576 |
| 27. |
Gray, S.,
and Levine, M.
(1996)
Genes Dev.
10,
700-710 |
| 28. | Takagi, T., Moribe, H., Kondoh, H., and Higashi, Y. (1998) Development 125, 21-31[Abstract] |
| 29. |
Postigo, A. A.,
and Dean, D. C.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6391-6396 |
This article has been cited by other articles:
![]() |
N. Herranz, D. Pasini, V. M. Diaz, C. Franci, A. Gutierrez, N. Dave, M. Escriva, I. Hernandez-Munoz, L. Di Croce, K. Helin, et al. Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor Mol. Cell. Biol., August 1, 2008; 28(15): 4772 - 4781. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Solanas, M. Porta-de-la-Riva, C. Agusti, D. Casagolda, F. Sanchez-Aguilera, M. J. Larriba, F. Pons, S. Peiro, M. Escriva, A. Munoz, et al. E-cadherin controls {beta}-catenin and NF-{kappa}B transcriptional activity in mesenchymal gene expression J. Cell Sci., July 1, 2008; 121(13): 2224 - 2234. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells Cancer Res., April 1, 2008; 68(7): 2479 - 2488. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beltran, I. Puig, C. Pena, J. M. Garcia, A. B. Alvarez, R. Pena, F. Bonilla, and A. G. de Herreros A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition Genes & Dev., March 15, 2008; 22(6): 756 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, S. El-Naggar, D. S. Darling, Y. Higashi, and D. C. Dean Zeb1 links epithelial-mesenchymal transition and cellular senescence Development, February 1, 2008; 135(3): 579 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Olmeda, G. Moreno-Bueno, J. M. Flores, A. Fabra, F. Portillo, and A. Cano SNAI1 Is Required for Tumor Growth and Lymph Node Metastasis of Human Breast Carcinoma MDA-MB-231 Cells Cancer Res., December 15, 2007; 67(24): 11721 - 11731. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Konopka, J. Tekiela, M. Iverson, C. Wells, and S. A. Duncan Junctional Adhesion Molecule-A Is Critical for the Formation of Pseudocanaliculi and Modulates E-cadherin Expression in Hepatic Cells J. Biol. Chem., September 21, 2007; 282(38): 28137 - 28148. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, C. Sloss, X. Zhang, S. W. Lee, and J. C. Cusack Membrane-Bound Heparin-Binding Epidermal Growth Factor Like Growth Factor Regulates E-Cadherin Expression in Pancreatic Carcinoma Cells Cancer Res., September 15, 2007; 67(18): 8486 - 8493. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, M. Zheng, G. Liu, W. Xia, P. J. McKeown-Longo, M.-C. Hung, and J. Zhao Kruppel-Like Factor 8 Induces Epithelial to Mesenchymal Transition and Epithelial Cell Invasion Cancer Res., August 1, 2007; 67(15): 7184 - 7193. [Abstract] [Full Text] [PDF] |
||||